Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China.
10.3760/cma.j.cn112150-20211203-01117
- Author:
Ting ZHANG
1
;
Xue Fei BAI
2
;
Wen WANG
3
;
Xiao Xue LIU
4
;
Xi Xi ZHANG
5
;
Da Yan WANG
6
;
Shao Bai ZHANG
7
;
Zhi Ping CHEN
8
;
Han Qing HE
9
;
Zhuo Ying HUANG
10
;
Ai Qiang XU
11
;
Zhi Bin PENG
12
;
Lu Zhao FENG
1
;
Wen Zhou YU
5
;
Zijian FENG
13
Author Information
1. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100730, China.
2. Institute of Public Health Service Information, Sichuan Center for Disease Control and Prevention, Chengdu 610041, China.
3. Department of Immunization Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China.
4. Department of Expanded Program of Immunization, Jinan Center for Disease Control and Prevention, Jinan 250021, China.
5. National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
6. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
7. Shaanxi Province Center for Disease Control and Prevention, Xi'an 710054, China.
8. Zhejiang Center for Disease Control and Prevention, Hangzhou 310051, China.
9. Department of Immunization, Zhejiang Center for Disease Control and Prevention, Hangzhou 310051, China.
10. Department of Immunization Program, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.
11. Shandong Provincial Center for Disease Control and Prevention, Jinan 250014, China.
12. Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
13. Chinese Preventive Medicine Association, Beijing 100021, China.
- Publication Type:Review
- MeSH:
Aged;
COVID-19;
COVID-19 Vaccines;
China;
Humans;
Infant;
Influenza Vaccines;
Influenza, Human/prevention & control*;
Pandemics/prevention & control*;
SARS-CoV-2;
Seasons;
Vaccination
- From:
Chinese Journal of Preventive Medicine
2022;56(2):103-107
- CountryChina
- Language:Chinese
-
Abstract:
Influenza is an infectious respiratory disease caused by the influenza viruses. Older people, infants and people with underlying medical conditions could have a higher risk of severe influenza symptoms and complications. The co-infection of Coronavirus Diseases 2019 (COVID-19) with influenza viruses could lead to the complication of prevention, diagnosis, control, treatment, and recovery of COVID-19. Influenza vaccine and COVID-19 vaccine overlapped in target populations, vaccination time, and inoculation units. Although there was insufficient evidence on the immunogenicity and safety of co-administration of influenza vaccine and COVID-19 vaccine, World Health Organization and some countries recommended co-administration of inactivated influenza vaccine and COVID-19 vaccine. This review summarized domestic and international vaccination policies and research progress, and put forward corresponding suggestions in order to provide scientific support for the formulation of vaccination strategy on seasonal influenza vaccine and COVID-19 vaccine.
